Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Freise KJ"'
Publikováno v:
Clinical Pharmacology & Therapeutics; Dec2017, Vol. 102 Issue 6, p970-976, 7p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mock DM, Matthews NI, Zhu S, Strauss RG, Schmidt RL, Zimmerman MB, Nalbant D, Freise KJ, Saleh M, Veng-Pedersen P, Widness JA, Mock, Donald M, Matthews, Nell I, Zhu, Shan, Strauss, Ronald G, Schmidt, Robert L, Zimmerman, M Bridget, Nalbant, Demet, Freise, Kevin J, Saleh, Mohammad
Publikováno v:
Transfusion; May2012, Vol. 52 Issue 5, p963-973, 11p
Autor:
Chang CA; AbbVie Inc., South San Francisco, California, United States., Emberley E; AbbVie Inc., South San Francisco, California, United States., D'Souza AL; AbbVie Inc., South San Francisco, California, United States., Zhao W; AbbVie Inc., South San Francisco, California, United States., Cosgrove C; AbbVie Inc., North Chicago, Illinois, United States., Parrish KE; AbbVie Inc., North Chicago, Illinois, United States., Mitra D; AbbVie Inc., North Chicago, Illinois, United States., Payson E; AbbVie Inc., South San Francisco, California, United States., Oleksijew A; AbbVie Inc., North Chicago, Illinois, United States., Ellis P; AbbVie Inc., North Chicago, Illinois, United States., Rodriguez L; AbbVie Inc., North Chicago, Illinois, United States., Duggan R; AbbVie Inc., North Chicago, Illinois, United States., Hrusch C; AbbVie Inc., North Chicago, Illinois, United States., Lasko L; AbbVie Inc., North Chicago, Illinois, United States., Assaily W; AbbVie Inc., South San Francisco, California, United States., Zheng P; AbbVie Inc., South San Francisco, California, United States., Liu W; AbbVie Inc., South San Francisco, California, United States., Hernandez A Jr; AbbVie Inc., Worcester, Massachusetts, United States., McCarthy K; AbbVie Inc., Worcester, Massachusetts, United States., Zhang Z; AbbVie Inc., South San Francisco, California, United States., Rha G; AbbVie Inc., North Chicago, Illinois, United States., Cao Z; AbbVie Inc., North Chicago, Illinois, United States., Li Y; AbbVie Inc., North Chicago, Illinois, United States., Perng O; AbbVie Inc., South San Francisco, California, United States., Campbell J; AbbVie Inc., South San Francisco, California, United States., Zhang G; AbbVie Inc., South San Francisco, California, United States., Curran TS; AbbVie Inc., South San Francisco, California, United States., Bruncko M; AbbVie Inc., North Chicago, Illinois, United States., Marvin CC; AbbVie Inc., North Chicago, Illinois, United States., Hobson AD; AbbVie Inc., Worcester, Massachusetts, United States., McPherson M; AbbVie Inc., Worcester, Massachusetts, United States., Uziel T; AbbVie Inc., North Chicago, Illinois, United States., Pysz MA; AbbVie Inc., South San Francisco, California, United States., Zhao X; AbbVie Inc., South San Francisco, California, United States., Bankovich A; Link Cell Therapies, Inc, South San Francisco, California, United States., Hayflick J; AbbVie Inc., South San Francisco, California, United States., McDevitt M; AbbVie Inc., South San Francisco, California, United States., Freise KJ; AbbVie Inc., North Chicago, Illinois, United States., Morgan-Lappe S; AbbVie Inc., North Chicago, Illinois, United States., Purcell JW; AbbVie Inc., South San Francisco, California, United States.
Publikováno v:
Blood [Blood] 2024 May 03. Date of Electronic Publication: 2024 May 03.
Autor:
D'Souza A; Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI., Shah N; Division of Hematology and Oncology, University of California, San Francisco, San Francisco, CA., Rodriguez C; Medical Oncology and Hematology, Wake Forest University School of Medicine, Winston-Salem, NC., Voorhees PM; Plasma Cell Disorders Division, Department of Hematologic Oncology & Blood Disorders, Levine Cancer Institute, Atrium Health/Wake Forest Baptist, Charlotte, NC., Weisel K; Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Bueno OF; AbbVie, Inc, North Chicago, IL., Pothacamury RK; AbbVie, Inc, North Chicago, IL., Freise KJ; AbbVie, Inc, North Chicago, IL., Yue S; AbbVie, Inc, North Chicago, IL., Ross JA; AbbVie, Inc, North Chicago, IL., Polepally AR; AbbVie, Inc, North Chicago, IL., Talati C; AbbVie, Inc, North Chicago, IL., Lee S; AbbVie, Inc, North Chicago, IL., Jin Z; AbbVie, Inc, North Chicago, IL., Buelow B; TeneoBio, Inc, Newark, CA., Vij R; Washington University School of Medicine, St Louis, MO., Kumar S; Department of Hematology, Mayo Clinic, Rochester, MN.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 Nov 01; Vol. 40 (31), pp. 3576-3586. Date of Electronic Publication: 2022 Aug 27.
Autor:
Clark TP; Nexcyon Pharmaceuticals, Inc., Madison, Wisconsin, USA., Linton DD; Nexcyon Pharmaceuticals, Inc., Madison, Wisconsin, USA., Freise KJ; Nexcyon Pharmaceuticals, Inc., Madison, Wisconsin, USA., Reinemeyer C; East Tennessee Clinical Research, Inc., Rockwood, Tennessee, USA., Newkirk KM; College of Veterinary Medicine, Biomedical and Diagnostic Sciences Department, University of Tennessee, Knoxville, Tennessee, USA., Aulbach A; MPI Research, Inc., Mattawan, Michigan, USA., Lin TL; Nexcyon Pharmaceuticals, Inc., Madison, Wisconsin, USA.
Publikováno v:
Journal of veterinary pharmacology and therapeutics [J Vet Pharmacol Ther] 2022 Jul; Vol. 45 Suppl 1, pp. S67-S84.
Autor:
Freise KJ; Nexcyon Pharmaceuticals, Inc., Madison, Wisconsin, USA., Reinemeyer C; East Tennessee Clinical Research, Inc., Rockwood, Tennessee, USA., Warren K; Covance Laboratories, Inc., Madison, Wisconsin, USA., Lin TL; Nexcyon Pharmaceuticals, Inc., Madison, Wisconsin, USA., Clark TP; Nexcyon Pharmaceuticals, Inc., Madison, Wisconsin, USA.
Publikováno v:
Journal of veterinary pharmacology and therapeutics [J Vet Pharmacol Ther] 2022 Jul; Vol. 45 Suppl 1, pp. S31-S39.
Autor:
Clark TP; Nexcyon Pharmaceuticals, Inc., Madison, Wisconsin, USA., Linton DD; Nexcyon Pharmaceuticals, Inc., Madison, Wisconsin, USA.; Deborah D. Linton, DL Veterinary Consulting, LLC, Florida, USA., Freise KJ; Nexcyon Pharmaceuticals, Inc., Madison, Wisconsin, USA.; Kevin J. Freise, AbbVie Inc., North Chicago, Illinois, USA., Lin TL; Nexcyon Pharmaceuticals, Inc., Madison, Wisconsin, USA.; Ting-Li Lin, Briostat, LLC, Madison, Wisconsin, USA.
Publikováno v:
Journal of veterinary pharmacology and therapeutics [J Vet Pharmacol Ther] 2022 Jul; Vol. 45 Suppl 1, pp. S52-S66.
Autor:
Clark TP; Nexcyon Pharmaceuticals, Inc., Madison, Wisconsin, USA., Linton DD; Nexcyon Pharmaceuticals, Inc., Madison, Wisconsin, USA.; Deborah D. Linton, DL Veterinary Consulting, LLC, Rotonda West, Florida, USA., Freise KJ; Nexcyon Pharmaceuticals, Inc., Madison, Wisconsin, USA.; Kevin J. Freise, AbbVie Inc., North Chicago, Illinois, USA., Lin TL; Nexcyon Pharmaceuticals, Inc., Madison, Wisconsin, USA.; Ting-Li Lin, Briostat, LLC, Madison, Wisconsin, USA.
Publikováno v:
Journal of veterinary pharmacology and therapeutics [J Vet Pharmacol Ther] 2022 Jul; Vol. 45 Suppl 1, pp. S40-S51.